CIK 0001638097 · Non-accelerated filer<br>Smaller reporting company
Entera Bio Ltd.
Sign in to watch- Ticker
- ENTX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- Israel
- Entity type
- operating
- Phone
- 972-2-532-7151
- Business address
- KIRYAT HADASSAH, MINRAV BUILDING, FIFTH FLOOR, JERUSALEM, Israel, 9112002
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-01-01 | GARCEAU ROGER Director | Grant or award · Stock Option (right to buy) | +108,333 | 108,333 | ||
| 2024-01-01 | Malca Yonatan Director | Grant or award · Stock Option (right to buy) | +108,333 | 108,333 | ||
| 2024-01-01 | OSTROV GERALD M Director | Grant or award · Stock Option (right to buy) | +108,333 | 108,333 | ||
| 2024-01-01 | Mayron Ron Director | Grant or award · Stock Option (right to buy) | +108,333 | 108,333 | ||
| 2024-01-01 | LIEBERMAN GERALD M Director | Grant or award · Stock Option (right to buy) | +108,333 | 108,333 | ||
| 2024-01-01 | Ellis Sean Director | Grant or award · Stock Option (right to buy) | +108,333 | 108,333 | ||
| 2023-12-22 | LIEBERMAN GERALD M Director | Purchase | +23,952 | $0.71 | $17K | 226,961 |
| 2023-12-22 | LIEBERMAN GERALD M Director | Purchase · Warrants (right to buy) | +23,952 | $0.13 | $3K | 23,952 |
| 2023-12-22 | Toledano Miranda Jayne Chief Executive Officer | Purchase | +23,952 | $0.71 | $17K | 110,752 |
| 2023-12-22 | Toledano Miranda Jayne Chief Executive Officer | Purchase · Warrants (right to buy) | +23,952 | $0.13 | $3K | 23,952 |
| 2023-09-13 | Taitel Haya Director | Grant or award · Stock Option (right to buy) | +33,368 | 33,368 | ||
| 2023-09-13 | Toledano Miranda Jayne Chief Executive Officer | Grant or award · Stock Option (right to buy) | +350,000 | 350,000 | ||
| 2023-08-22 | Taitel Haya Director | Purchase | +18,000 | $0.62 | $11K | 18,000 |
| 2023-08-21 | LIEBERMAN GERALD M Director | Purchase | +20,000 | $0.59 | $12K | 214,209 |
| 2023-08-21 | Ellis Sean Director | Purchase | +40,000 | $0.60 | $24K | 102,100 |
| 2023-04-24 | Santora Arthur C II Chief Medical Officer | Grant or award · Stock Option (right to buy) | +35,000 | 35,000 | ||
| 2023-04-24 | Yaacov-Garbeli Dana Chief Financial Officer | Grant or award · Stock Option (right to buy) | +190,000 | 190,000 | ||
| 2023-04-24 | Galitzer Hillel Chief Operating Officer | Grant or award · Stock Option (right to buy) | +210,000 | 210,000 | ||
| 2023-04-04 | Toledano Miranda Jayne Chief Executive Officer | Purchase | +30,000 | $1.01 | $30K | 86,800 |
| 2023-01-02 | GARCEAU ROGER Director | Grant or award · Stock Option (right to buy) | +89,041 | 89,041 |
Page 5 of 8 · 147 trades